Lingerie and swimwear company Van de Velde reported 2017 revenue came in slightly higher at €209.0 million, versus €206.6 million in 2016 and net profit was stable at €33.9 million compared to €33.6 million in 2016.
Investment holding company Iep Invest reported revenue was flat in 2017 at €13.3 million compared to €13.5 million in 2016 but profit had nearly doubled for the year.
Port of Rotterdam reported revenue increased in 2017 to €712.1 million from €675.4 million in 2016 due to higher land leases and strong growth in container throughput with a return to the growth trend seen before 2016.
Investment bank NIBC announced it intended to proceed with an Initial Public Offering and was applying for listing of its shares on Euronext Amsterdam.
Electricity grid operator Elia Group reported revenue was up by 2.2% in 2017 at €887.5 million, compared to €868.1 million in 2016, with net profit higher by 27.4%.
Biotechnology drug company Galapagos reported revenue increased in 2017 to €155.9 million compared to €151.6 million in 2016.
Commercial property investor Montea reported rental income was stable in 2017 at €40.8 million with an increase in the fair value of the portfolio of 30% to €719 million.
Electricity grid operator TenneT reported revenue rose by 22% in 2017 to €3,948 million from €3,227 million in 2016 as a result of significant investments in new assets over the past years.
Electronics manufacturer Neways Electronics International reported revenue increased by 11.6% in 2017 to €438.7 million from €393.2 million in 2016.
Commercial property investor Leasinvest Real Estate reported rental income was stable in 2017 at €56.9 million compared to €56.7 million in 2016.
Financial services group Van Lanschot Kempen reported income rose by 7% to €514.8 million compared to €481.8 million in 2016 with a 36% increase in net profit to €94.9 million, up from €69.8 million.
Geotechnical and science services company Fugro reported revenue decline in 2017 by -15.7% to €1,497.4 million from €1,775.9 million in 2016 after a particularly challenging year in the oil and gas market.
Biopharmaceutical company UCB reported revenue was up 9% in 2017 at €4,530 million from €4,147 million in 2016 driven by core product sales growth of 13%.
Mining and metals processor Nyrstar reported revenue increased by 28% in 2017 to €3,530 million compared to €2,763 million in 2016, mainly due to a 38% increase in zinc prices.
Biopharmaceutical company Ablynx reported revenue was lower in 2017 at €55.5 million compared to €85.2 million in 2016 due to lower upfront and grant payments.